DA
DCF Advisers’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Hold |
0
| – | – | – | 83 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 86 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 74 |
|
|
2021
Q2 | – | Sell |
-17,286
| Closed | -$485K | – | 82 |
|
|
2021
Q1 | $485K | Sell |
17,286
-21,214
| -55% | -$595K | 0.21% | 63 |
|
|
2020
Q4 | $1M | Sell |
38,500
-18,000
| -32% | -$468K | 0.41% | 41 |
|
|
2020
Q3 | $2.1M | Buy |
56,500
+8,000
| +16% | +$297K | 1.07% | 26 |
|
|
2020
Q2 | $2.49M | Buy |
48,500
+26,500
| +120% | +$1.36M | 1.39% | 20 |
|
|
2020
Q1 | $694K | Buy |
22,000
+7,000
| +47% | +$221K | 0.45% | 36 |
|
|
2019
Q4 | $894K | Buy |
+15,000
| New | +$894K | 0.57% | 30 |
|